![Leo Pharma Enters into a Sub-Licensing Agreement with Bausch Health to Develop and Commercialize Brodalumab Leo Pharma Enters into a Sub-Licensing Agreement with Bausch Health to Develop and Commercialize Brodalumab](https://pharmashots.com/public/images/20211115234408_ogImage_4.png)
Leo Pharma Enters into a Sub-Licensing Agreement with Bausch Health to Develop and Commercialize Brodalumab
![Brodalumab for the treatment of moderate-to-severe psoriasis: case series and literature review. - Abstract - Europe PMC Brodalumab for the treatment of moderate-to-severe psoriasis: case series and literature review. - Abstract - Europe PMC](https://europepmc.org/articles/PMC6628099/bin/CCID-12-509-g0001.jpg)
Brodalumab for the treatment of moderate-to-severe psoriasis: case series and literature review. - Abstract - Europe PMC
![Immunogenicity and skin clearance recapture in clinical studies of brodalumab - Journal of the American Academy of Dermatology Immunogenicity and skin clearance recapture in clinical studies of brodalumab - Journal of the American Academy of Dermatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/04a4a228-4247-49bb-bfdc-09de8ee8c1df/gr1_lrg.jpg)
Immunogenicity and skin clearance recapture in clinical studies of brodalumab - Journal of the American Academy of Dermatology
![Vuoi portare con me una crema per la psoriasi in aereo per la Cina - ragionevole? | Travelplansinmomhands Vuoi portare con me una crema per la psoriasi in aereo per la Cina - ragionevole? | Travelplansinmomhands](https://travelplansinmomhands.com/storage/img/images_8/want_to_carry_a_psoriasis_cream_with_me_on_plane_to_china_reasonable.png)
Vuoi portare con me una crema per la psoriasi in aereo per la Cina - ragionevole? | Travelplansinmomhands
![PDF) Complete clearance and psoriasis area and severity index response for brodalumab and ustekinumab in AMAGINE‐2 and ‐3 PDF) Complete clearance and psoriasis area and severity index response for brodalumab and ustekinumab in AMAGINE‐2 and ‐3](https://i1.rgstatic.net/publication/342928163_Complete_clearance_and_psoriasis_area_and_severity_index_response_for_brodalumab_and_ustekinumab_in_AMAGINE-2_and_-3/links/5f4421d2458515b7294ca37f/largepreview.png)
PDF) Complete clearance and psoriasis area and severity index response for brodalumab and ustekinumab in AMAGINE‐2 and ‐3
![FDA panel unanimously backs Valeant's suicide-linked psoriasis med, but serious competition awaits | Fierce Pharma FDA panel unanimously backs Valeant's suicide-linked psoriasis med, but serious competition awaits | Fierce Pharma](https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/2016-07/valeanthq_3.jpg?VersionId=FFQsdSK2qhvrTMC1Cd2g0OQolmEflkKh)
FDA panel unanimously backs Valeant's suicide-linked psoriasis med, but serious competition awaits | Fierce Pharma
![PDF) Brodalumab for the treatment of moderate-to-severe psoriasis: case series and literature review PDF) Brodalumab for the treatment of moderate-to-severe psoriasis: case series and literature review](https://i1.rgstatic.net/publication/334367070_Brodalumab_for_the_treatment_of_moderate-to-severe_psoriasis_case_series_and_literature_review/links/5d25e07ba6fdcc2462d0bfbb/largepreview.png)
PDF) Brodalumab for the treatment of moderate-to-severe psoriasis: case series and literature review
![Improved Plaque Psoriasis Symptoms and Satisfaction With Brodalumab Therapy Reported - Dermatology Advisor Improved Plaque Psoriasis Symptoms and Satisfaction With Brodalumab Therapy Reported - Dermatology Advisor](https://www.dermatologyadvisor.com/wp-content/uploads/sites/20/2022/02/plaque-psoriasis_SS2523807-860x571.jpg)
Improved Plaque Psoriasis Symptoms and Satisfaction With Brodalumab Therapy Reported - Dermatology Advisor
![Rapid and Sustained Improvement in a Patient With Plaque Psoriasis Switched to Brodalumab After Failing Treatment Clearance on Six Other Biologic Therapies - JDDonline - Journal of Drugs in Dermatology Rapid and Sustained Improvement in a Patient With Plaque Psoriasis Switched to Brodalumab After Failing Treatment Clearance on Six Other Biologic Therapies - JDDonline - Journal of Drugs in Dermatology](https://s3.amazonaws.com/dl.jddonline.com/articleimages/19_1_1/Figure-2.jpg)